Lupin unveils Neuro-rehabilitation center in Mumbai

Published On 2023-02-15 07:45 GMT   |   Update On 2023-02-15 07:45 GMT
Advertisement

Mumbai: Pharma major, Lupin Limited, has announced the launch of a world-class Neuro-rehabilitation center, Atharv Ability in Bandra Kurla Complex (BKC), Mumbai, India.

"The first-of-its-kind robotic and computer-assisted, multi-disciplinary neuro-rehabilitation center is one of the most advanced rehabilitation centers in the country," the company stated.

Atharv Ability offers a range of rehabilitation programs for post-stroke patients, patients with traumatic brain injury, spinal cord injury, and pediatric neurological conditions as well as for other neurological conditions including Parkinsons, cerebral palsy and multiple sclerosis.

Advertisement

The neuro-rehabilitation center has a comprehensive suite of state-of-the-art equipment including an endeffector based robotic solution for gait and hand training, balance training and postural control, occupational therapy, speech therapy and swallowing therapy, cognitive behavioral therapy, aqua therapy, visual therapy, and virtual reality amongst others.

For the first time in India, Atharv Ability has introduced a dedicated home environment simulation space for “Activities of Daily Life” training that supports patient daily life and their interaction with the environment. The training improves their functionality and cognitive abilities and helps them integrate back into normal life.

Commenting on the launch, Rajeev Sibal, President – India Region Formulations, Lupin said, “Neurological disorders and events lead to disability, creating an urgent need for multi-disciplinary centers with advanced therapeutic care delivered by neurological rehabilitation experts under one roof. This is why we have launched Atharv Ability, an innovative and futuristic neuro-rehabilitation center to improve health outcomes and quality of life of patients with neuro-disabilities through world-class patient-centric rehabilitation that is affordable and accessible for all.”

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.

Read also: Lupin bags tentative USFDA nod for Dolutegravir, Emtricitabine and Tenofovir Alafenamide Tablets to control HIV infections

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News